Deciphering the role of PGC-1α in neurological disorders: from mitochondrial dysfunction to synaptic failureJessica D.Panes, Aline Wendt, Oscar Ramirez-Molina, Patricio A.Castro, Jorge Fuentealba237-245
Dying by fire: noncanonical functions of autophagy proteins in neuroinflammation and neurodegenerationAlexis D.Rickman, Addison Hilyard, Bradlee L.Heckmann246-250
Transcranial magnetic stimulation in animal models of neurodegenerationMohammad Uzair, Turki Abualait, Muhammad Arshad, Woo-Kyoung Yoo, Ali Mir, Reem Fahd Bunyan, Shahid Bashir251-265
SYNGR4 and PLEKHB1 deregulation in motor neurons of amyotrophic lateral sclerosis models: potential contributions to pathobiologyRita F.Marques, Kent E.Duncan266-270
Challenges in developing therapeutic strategies for mild neonatal encephalopathyAlice Mc, Douall, Guido Wassink, Laura Bennet, Alistair J.Gunn, Joanne O.Davidson277-282
Delving into the recent advancements of spinal cord injury treatment: a review of recent progressJoseph A.Flack, Krishna Deo Sharma, Jennifer Yanhua Xie283-291
Hyperglycemia in acute ischemic stroke: physiopathological and therapeutic complexityFederica Ferrari, Antonio Moretti, Roberto Federico Villa292-299
Inserting new synaptic connections into damaged neural circuits: towards synapse therapy?Ithai Rabinowitch300-301
Celeboxib-mediated neuroprotection in focal cerebral ischemia: an interplay between unfolded protein response and inflammationMaría Santos-Galdiano, Diego Pérez-Rodríguez, Arsenio Fernández-López302-303
